Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2025-12-26 @ 3:21 AM
Study NCT ID:
NCT07175220
Status:
RECRUITING
Last Update Posted:
2025-11-18
First Post:
2025-09-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects
Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-09
Start Date Type:
ACTUAL
Primary Completion Date:
2028-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-09
First Submit QC Date:
None
Study First Post Date:
2025-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-16
Last Update Post Date:
2025-11-18
Last Update Post Date Type:
ESTIMATED